PerkinElmer Appoints Aaron Geist as Vice President, Business Development
Extensive Health Sciences Industry Experience Will Drive Company's Business Development Strategy
BOSTON - Jan. 19, 2006 - PerkinElmer, Inc. (NYSE: PKI), a global technology leader in the health sciences and photonics markets, today announced the appointment of Dr. Aaron Geist as Vice President, Business Development for the Company. Dr. Geist will be responsible for developing PerkinElmer's strategic partnerships and acquisition opportunities.
Geist joins PerkinElmer from Robert W. Baird where he served as Director and Senior Research Analyst. In this role, he was responsible for generating investor research on 22 life sciences, medical diagnostics and medical device companies, and was chosen as a top analyst by both The Wall Street Journal and Forbes/StarMine in 2004. He previously worked in medical research with a specialization in infectious diseases. Aaron holds a Ph.D. in microbiology and molecular virology from Thomas Jefferson University in Philadelphia, Pennsylvania, and bachelor of science degrees in genetics and biology from the University of Western Ontario in Canada.
'Aaron brings exceptional domain knowledge, market understanding and business acumen to his new role,' said Robert F. Friel, Vice Chairman of PerkinElmer, Inc. 'We look forward to his leadership in developing and growing the PerkinElmer business portfolio, particularly in the areas of molecular medicine, genetic screening and medical imaging.'
Factors Affecting Future Performance
This press release contains 'forward-looking' statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as 'believes,' 'intends,' 'anticipates,' 'plans,' 'expects,' 'projects,' 'forecasts,' 'will' and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our ability to identify a purchaser of the Company's semiconductor business, negotiate and consummate the sale of such business, including obtaining regulatory approvals; (2) economic and geopolitical forces that may limit any continued or expected economic or end market strengthening or recoveries; (3) risks related to our failure to introduce new products in a timely manner; (4) our ability to comply with financial covenants contained in our credit agreements and our debt instruments; (5) a delay in resolution of the Company's tax audits and an adverse determination with respect to the Company's tax audits by the Internal Revenue Service or other taxing authorities; (6) cyclical downturns continuing to affect several of the industries into which we sell our products; (7) our ability to adjust our operations to address unexpected changes; (8) our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business; (9) the loss of any of our licenses that may require us to stop selling products or lose competitive advantage; (10) competition; (11) regulatory compliance; (12) regulatory changes; (13) our failure to obtain and enforce intellectual property protection; (14) our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets; (15) other factors which we describe under the caption 'Forward-Looking Information and Factors Affecting Future Performance' in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.